We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+4.33%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.68B
AUM Growth
-$209M
Cap. Flow
-$341M
Cap. Flow %
-9.26%
Top 10 Hldgs %
13.58%
Holding
1,437
New
112
Increased
524
Reduced
590
Closed
111

Sector Composition

Rank Sector Weight
1 Technology 12.63%
2 Healthcare 11.47%
3 Financials 11.29%
4 Industrials 9.35%
5 Consumer Discretionary 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IYE icon
401
iShares US Energy ETF
IYE
$1.74B
$1.94M 0.05%
46,171
+110
+0.2% +$4.5K
LQD icon
402
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
$1.94M 0.05%
16,899
-31,145
-65% -$3.59M
MTRN icon
403
Materion
MTRN
$4.39B
$1.93M 0.05%
35,600
-50
-0.1% -$2.71K
ETG
404
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
$1.8B
$1.93M 0.05%
113,212
-301
-0.3% -$5.12K
GOOS
405
Canada Goose Holdings
GOOS
$872M
$1.89M 0.05%
32,060
-1,500
-4% -$63.2K
ETP
406
DELISTED
Energy Transfer Partners, L.P.
ETP
$1.89M 0.05%
99,074
-99,354
-50% -$1.83M
VIG icon
407
Vanguard Dividend Appreciation ETF
VIG
$111B
$1.87M 0.05%
18,370
+45
+0.2% +$4.59K
FBT icon
408
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
$1.86M 0.05%
13,298
+2,941
+28% +$404K
GDV icon
409
Gabelli Dividend & Income Trust
GDV
$2.6B
$1.84M 0.05%
81,549
+7,659
+10% +$172K
TECK icon
410
Teck Resources
TECK
$29.6B
$1.84M 0.05%
72,254
-1,059
-1% -$28.4K
ENLK
411
DELISTED
EnLink Midstream Partners, LP
ENLK
$1.84M 0.05%
118,338
-195,254
-62% -$3.02M
TLT icon
412
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
$1.82M 0.05%
14,932
-2,076
-12% -$248K
FEP icon
413
First Trust Europe AlphaDEX Fund
FEP
$526M
$1.81M 0.05%
47,081
+2,124
+5% +$85.4K
WDC icon
414
Western Digital
WDC
$188B
$1.81M 0.05%
30,876
+4,669
+18% +$297K
BSV icon
415
Vanguard Short-Term Bond ETF
BSV
$44.7B
$1.8M 0.05%
23,018
-2,955
-11% -$231K
MMP
416
DELISTED
Magellan Midstream Partners, L.P.
MMP
$1.8M 0.05%
26,004
-6,923
-21% -$465K
CM icon
417
Canadian Imperial Bank of Commerce
CM
$108B
$1.79M 0.05%
41,112
DINO icon
418
HF Sinclair
DINO
$16.3B
$1.78M 0.05%
25,997
-43,970
-63% -$2.93M
FCX icon
419
Freeport-McMoran
FCX
$90B
$1.78M 0.05%
102,961
-11,282
-10% -$191K
FXO icon
420
First Trust Financials AlphaDEX Fund
FXO
$1.13B
$1.77M 0.05%
56,648
-4,927
-8% -$155K
ESRX
421
DELISTED
Express Scripts Holding Company
ESRX
$1.77M 0.05%
22,878
-1,632
-7% -$122K
TMUS icon
422
T-Mobile US
TMUS
$185B
$1.76M 0.05%
29,383
-1,204
-4% -$71.3K
ETV
423
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.71B
$1.75M 0.05%
113,450
+4,500
+4% +$68.6K
BAX icon
424
Baxter International
BAX
$13.5B
$1.73M 0.05%
23,468
+467
+2% +$32.9K
LPT
425
DELISTED
Liberty Property Trust
LPT
$1.73M 0.05%
39,100
-400
-1% -$16.9K

Similar funds

Oppenheimer & Co's Q2 2018 Portfolio in Review

As of Q2 2018, Oppenheimer & Co held 1,437 positions worth $3.68B, down 5.4% from $3.89B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co withdrew a net $341M in Q2 2018, closing 111 positions and reducing 590 holdings. Its most notable exit was Monsanto Co, an estimated $9.28M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Oppenheimer & Co opened a new position in Thor Industries worth $3.01M.

  • Oppenheimer & Co's largest Q2 2018 buy was Thor Industries: 30,900 shares worth $3.01M.
  • Oppenheimer & Co added most to AT&T in Q2 2018, an estimated $7.02M increase.
  • Oppenheimer & Co's biggest Q2 2018 reduction was Foundation Medicine, Inc., cutting an estimated $63.6M.
  • Oppenheimer & Co fully exited Monsanto Co in Q2 2018, selling an estimated $9.28M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.68B portfolio in Q2 2018.
  • Oppenheimer & Co opened 112 new positions and closed 111 in Q2 2018.
  • Oppenheimer & Co's portfolio value fell 5.4% quarter-over-quarter to $3.68B.

Based on Oppenheimer & Co's 13F filing for Q2 2018, filed 10 Aug 2018.